it's written as "one of the firsts" (emd are now on patient #3)
- "It was one of the first dosages in Australia, alongside another given by Victorian psychiatrist Eli Kotler the same week"
From mid 2021 announcement
- Emyria Limited (ASX:EMD) has appointed consultant psychiatrist Dr Eli Kotler as principal investigator for its upcoming clinical trial on MDMA-assisted psychotherapy for treatment-resistant Post Traumatic Stress Disorder (PTSD), known as EMDMA-001.
Ann: Webinar Presentation, page-10
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.001(1.72%) |
Mkt cap ! $24.13M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.9¢ | 5.6¢ | $1.638K | 28.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 622 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 11378 | 1 |
View Market Depth
| Last trade - 15.31pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.001 ( 1.75 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.8¢ | 750 | ||
| Last updated 13.36pm 30/05/2024 ? | |||||
| EMD (ASX) Chart |